Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.

Lee HJ, Lee OJ, Jang KT, Bae YK, Chung JY, Eom DW, Kim JM, Yu E, Hong SM.

Am J Clin Pathol. 2013 Feb;139(2):167-76. doi: 10.1309/AJCPS54RTFCTHGWX.

PMID:
23355201
2.

Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.

Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.

Pol J Pathol. 2011;62(1):19-24.

3.

Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.

Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L, Fan S.

Hum Pathol. 2013 Jul;44(7):1357-64. doi: 10.1016/j.humpath.2012.10.025. Epub 2013 Jan 31.

PMID:
23375645
4.

Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, Han J, Kim J.

Eur J Cardiothorac Surg. 2003 Sep;24(3):441-9.

PMID:
12965318
5.
6.

Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma.

Kim MJ, Gu MJ, Chang HK, Yu E.

Histopathology. 2015 Mar;66(4):508-16. doi: 10.1111/his.12566. Epub 2015 Jan 12.

PMID:
25400081
7.

Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma.

Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae HI, Lee HJ, Hong SM.

Pathology. 2013 Oct;45(6):567-73. doi: 10.1097/PAT.0b013e3283650bab.

PMID:
24018801
8.

Immunohistochemical investigation of tumorigenic pathways in sinonasal intestinal-type adenocarcinoma. A tissue microarray analysis of 62 cases.

Franchi A, Palomba A, Fondi C, Miligi L, Paglierani M, Pepi M, Santucci M.

Histopathology. 2011 Jul;59(1):98-105. doi: 10.1111/j.1365-2559.2011.03887.x. Epub 2011 Jun 13.

PMID:
21668475
9.

The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.

Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.

Eur Urol. 2006 May;49(5):839-45; discussion 845. Epub 2006 Jan 6.

PMID:
16426728
11.

L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.

Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.

Ann Surg Oncol. 2007 May;14(5):1703-11. Epub 2007 Jan 9.

PMID:
17211730
12.

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA.

J Clin Oncol. 2004 Apr 1;22(7):1242-52.

PMID:
15051772
13.

Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.

Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.

J Pathol. 2000 Dec;192(4):427-32.

PMID:
11113858
14.

Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.

Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D.

Mod Pathol. 1998 Sep;11(9):805-13.

PMID:
9758359
15.

S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.

Roh J, Knight S, Chung JY, Eo SH, Goggins M, Kim J, Cho H, Yu E, Hong SM.

J Clin Pathol. 2014 Mar;67(3):216-21. doi: 10.1136/jclinpath-2013-201883. Epub 2013 Sep 23.

PMID:
24062356
16.

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.

Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M.

J Pathol. 2000 Dec;192(4):433-9.

PMID:
11113859
17.

Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.

Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K.

Clin Cancer Res. 2000 Dec;6(12):4789-96.

18.

Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.

Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J.

Int J Surg Pathol. 2011 Dec;19(6):751-60. doi: 10.1177/1066896911414566. Epub 2011 Jul 26.

PMID:
21791486
19.

Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.

Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Cui X, Ajioka Y, Hatakeyama K.

Hum Pathol. 2008 Dec;39(12):1777-83. doi: 10.1016/j.humpath.2008.05.006. Epub 2008 Aug 12.

PMID:
18701136
20.

Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis.

Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN, Bosman FT.

J Pathol. 1997 Jul;182(3):331-8.

PMID:
9349237

Supplemental Content

Support Center